Tim Funnell

Partner • Monograph Capital

Tim trained as a Pharmacologist with Undergraduate degree from University of Cambridge and DPhil from the University of Oxford before joining the Boston Consulting Group’s London office. Since then Tim has been a biotech investor and company-builder at Syncona, Third Rock Ventures, and Oxford Sciences, gaining experience across therapeutic modalities and geographies. Tim leads Monograph’s investments in Aviado and Ascend.  

Also speaking

Elsa Abranches

Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • AstraZeneca

Bryan Poltilove

Operating Partner • BroadOak Partners

Ludwig Camusot

Chief Corporate Development Officer • Cell Matters

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.